UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 192

Sortiert nach

Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer

The New England journal of medicine, 2020-09, Vol.383 (10), p.944-957

2020

Link zum Volltext

Verfügbarkeit prüfen

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

The lancet oncology, 2015-03, Vol.16 (3), p.257-265

2015

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitors: a game changer for metastatic non-small-cell lung cancer

The lancet oncology, 2019-10, Vol.20 (10), p.1334-1335

2019

Link zum Volltext

Verfügbarkeit prüfen

Circulating free DNA concentration is an independent prognostic biomarker in lung cancer

The European respiratory journal, 2015-12, Vol.46 (6), p.1773-1780

2015

Link zum Volltext

Verfügbarkeit prüfen

Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial

The lancet oncology, 2022-09, Vol.23 (9), p.1180-1188

2022

Link zum Volltext

Verfügbarkeit prüfen

On the relevance of a testing algorithm for the detection of ROS1 -rearranged lung adenocarcinomas

Lung cancer (Amsterdam, Netherlands), 2014-02, Vol.83 (2), p.168-173

2014

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Trial of Sequential Chemoradiotherapy Compared With Concurrent Chemoradiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique–Groupe Français de Pneumo-Cancérologie NPC 95-01 Study

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5910-5917

2005

Link zum Volltext

Verfügbarkeit prüfen

Staging of nutrition disorders in non‐small‐cell lung cancer patients: utility of skeletal muscle mass assessment

Journal of cachexia, sarcopenia and muscle, 2019-08, Vol.10 (4), p.782-793

2019

Link zum Volltext

Verfügbarkeit prüfen

Is Nutritional Screening of Patients with Lung Cancer Optimal? An Expert Opinion Survey of French Physicians and Surgeons

Nutrition and cancer, 2019-08, Vol.71 (6), p.971-980

2019

Link zum Volltext

Verfügbarkeit prüfen

Class III β-tubulin expression in tumor cells predicts response and outcome in patients with non–small cell lung cancer receiving paclitaxel

Molecular cancer therapeutics, 2005-12, Vol.4 (12), p.2001-2007

2005

Link zum Volltext

Verfügbarkeit prüfen

Intravenous route for folate supplementation in a patient with celiac disease treated by pemetrexed-based chemotherapy for non-small-cell lung cancer

Journal of oncology pharmacy practice, 2023-04, Vol.29 (3), p.750-754

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparative efficacy and safety of licensed treatments for previously treated non-small cell lung cancer: A systematic review and network meta-analysis

PloS one, 2018-07, Vol.13 (7), p.e0199575

2018

Link zum Volltext

Verfügbarkeit prüfen

Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study)

PloS one, 2017-08, Vol.12 (8), p.e0182798-e0182798

2017

Link zum Volltext

Verfügbarkeit prüfen

Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: A randomized, open-label trial

Journal of the American Academy of Dermatology, 2016-06, Vol.74 (6), p.1077-1085

2016

Link zum Volltext

Verfügbarkeit prüfen

A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunity

BMC infectious diseases, 2018-12, Vol.18 (1), p.659-659, Article 659

2018

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer in never smokers – A review

European journal of cancer (1990), 2012-06, Vol.48 (9), p.1299-1311

2012

Link zum Volltext

Verfügbarkeit prüfen

Routine EGFR Molecular Analysis in Non-Small-Cell Lung Cancer Patients is Feasible: Exons 18–21 Sequencing Results of 753 Patients and Subsequent Clinical Outcomes

Lung, 2013-10, Vol.191 (5), p.491-499

2013

Link zum Volltext

Verfügbarkeit prüfen

Expression of Class III β-Tubulin Is Predictive of Patient Outcome in Patients with Non–Small Cell Lung Cancer Receiving Vinorelbine-Based Chemotherapy

Clinical cancer research, 2005-08, Vol.11 (15), p.5481-5486

2005

Link zum Volltext

Verfügbarkeit prüfen

Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes

Cancers, 2021-05, Vol.13 (10), p.2365

2021

Link zum Volltext

Verfügbarkeit prüfen

Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study

BMC cancer, 2018-10, Vol.18 (1), p.1013-1013, Article 1013

2018

Link zum Volltext

Verfügbarkeit prüfen

Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab

Journal of clinical medicine, 2020-11, Vol.9 (12), p.3861

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 192

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(186)
Mit Volltextzugriff
(176)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(115)
Life Sciences & Biomedicine
(110)
Humans
(101)
Oncology
(75)
Aged
(68)
Male
(68)
Female
(66)
Middle Aged
(65)
Adult
(43)
Lung Neoplasms - Drug Therapy
(42)
Respiratory System
(39)
Life Sciences
(38)
Lung Neoplasms - Pathology
(37)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(36)
Lung Cancer
(36)
Chemotherapy
(32)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(29)
Biological And Medical Sciences
(29)
Medical Sciences
(29)
Neoplasm Staging
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial

Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

Immune checkpoint inhibitors: a game changer for metastatic non-small-cell lung cancer

Circulating free DNA concentration is an independent prognostic biomarker in lung cancer

Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/ IFCT-1002

Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

On the relevance of a testing algorithm for the detection of ROS1 -rearranged lung adenocarcinomas

Randomized Phase III Trial of Sequential Chemoradiotherapy Compared With Concurrent Chemoradiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique–Groupe Français de Pneumo-Cancérologie NPC 95-01 Study

Staging of nutrition disorders in non‐small‐cell lung cancer patients: utility of skeletal muscle mass assessment

Is Nutritional Screening of Patients with Lung Cancer Optimal? An Expert Opinion Survey of French Physicians and Surgeons

Class III β-tubulin expression in tumor cells predicts response and outcome in patients with non–small cell lung cancer receiving paclitaxel

Intravenous route for folate supplementation in a patient with celiac disease treated by pemetrexed-based chemotherapy for non-small-cell lung cancer

Comparative efficacy and safety of licensed treatments for previously treated non-small cell lung cancer: A systematic review and network meta-analysis

Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study)

Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: A randomized, open-label trial

A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunity

Lung cancer in never smokers – A review

Routine EGFR Molecular Analysis in Non-Small-Cell Lung Cancer Patients is Feasible: Exons 18–21 Sequencing Results of 753 Patients and Subsequent Clinical Outcomes

Expression of Class III β-Tubulin Is Predictive of Patient Outcome in Patients with Non–Small Cell Lung Cancer Receiving Vinorelbine-Based Chemotherapy

Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes

Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study

Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab

Suchergebnisse filtern